MyMD Pharmaceuticals Inc. buy Quitte
Start price
04.06.18
/
50%
€169.72
Target price
07.11.18
€242.46
Performance (%)
-36.53%
End price
07.11.18
€107.72
Summary
This prediction ended on 07.11.18 with a price of €107.72. The BUY prediction by Quitte for MyMD Pharmaceuticals Inc. performed very badly with a performance of -36.53%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| MyMD Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | -1.306% | -0.778% | 9.149% | 57.505% |
| iShares Nasdaq 100 | 1.979% | -2.045% | 6.569% | 90.022% |
| iShares Nikkei 225® | 0.593% | 6.713% | 31.580% | 65.481% |
| iShares S&P 500 | 1.425% | -0.477% | 3.616% | 62.099% |
Comments by Quitte for this prediction
In the thread MyMD Pharmaceuticals Inc. diskutieren
nach dem Tiefschlag ist vor dem Anstieg
zumindest mit einer kurzfristigen Erholung ist vermutlich zu rechen
https://seekingalpha.com/news/3359914-akers-bio-34-percent-premarket-withdrawal-u-s-marketing-application-chlamydia-test
(Vom Mitglied beendet)